Floatz logo

Aldurazyme

Mucopolysaccharidosis I

Genzyme, a Sanofi CompanyPhase 4 / ApprovedDormant
A
84/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
77/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Mucopolysaccharidosis I cohort.

Asset / SponsorPhaseRating
IDURONIDASE, .ALPHA.-L-(8-HISTIDINE) (HUMAN)
University of California, San Francisco
Phase 4BBB
VALANAFUSP ALFA
ArmaGen, Inc
Phase 1/2BB
Rhidu
Genzyme, a Sanofi Company
Phase 3BB
Equine Atg
Masonic Cancer Center, University of Minnesota
Phase 2B
Genotropin
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Phase 2/3B

View all 15 →

Same molecule, other indications

Aldurazyme is also rated in:

Hurler syndromeDormant
A
Indicative ·
84 / 100
View asset →
Hurler-Scheie syndromeDormant
A
Indicative ·
84 / 100
View asset →
Scheie syndromeDormant
A
Indicative ·
84 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →